Understand the source comparison
Sleep Peptides Men Over 40 Deep Sleep: Full Protocol Comparison
DSIP Monotherapy DSIP 250mcg subcutaneous Inject 30 min before bed Week 2–3: noticeable; Week 4–6: peak effect $180–$240 Simple, effective for isolated deep sleep deficits. Won't fix circadian misalignment or cortisol issues. Thymalin + DSIP Combination Thymal
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- DSIP Monotherapy
- DSIP 250mcg subcutaneous
- Inject 30 min before bed
- Week 2–3: noticeable; Week 4–6: peak effect
- $180–$240
- Simple, effective for isolated deep sleep deficits. Won't fix circadian misalignment or cortisol issues.
- Thymalin + DSIP Combination
- Thymalin 10mg 3x/week + DSIP 250mcg nightly
- Thymalin evenings Mon/Wed/Fri; DSIP nightly
- Week 3–4: circadian improvement; Week 5–8: deep sleep increase
- $320–$400
- Best all-around protocol for men over 50 with multiple sleep issues (fragmented cycles + weak circadian rhythm).
- MK-677 + Sleep Hygiene
- MK-677 25mg oral nightly
- Take 2 hours before bed with light carbs
- Week 1–2: immediate Stage 4 increase
- $120–$160
- Highest immediate impact on deep sleep percentage. Side effects (appetite, mild water retention) limit long-term use for some.
- Epitalon Cycling
- Epitalon 10mg nightly for 10 days, twice yearly
- Inject before bed during cycle periods
- Month 2–3 post-cycle: gradual circadian strengthening
- $280–$350 (per cycle)
- Best for long-term circadian repair, not acute sleep restoration. Adjunct to other protocols.
- The combination protocol (Thymalin + DSIP) consistently produces the strongest polysomnography-validated results in men over 50 because it addresses both GABAergic deficit and circadian amplitude loss. MK-677 delivers faster subjective improvement but isn't technically a peptide. It's a ghrelin receptor agonist that indirectly stimulates growth hormone release, which extends Stage 4 sleep as a secondary effect. For research purposes, both peptide and non-peptide options have demonstrated efficacy in published trials.